Study Assesses Functional Deficits Due to HIV and Methamphetamine Use

The National Institute on Drug Abuse published an article by investigator Dr. Steven Paul Woods and collaborator, Kaitlin Blackstone, on the burden of methamphetamine use and human immunodeficiency virus imposes on daily functioning. 


Teens turn to text messages for AIDS advice in Zambia

In an article by Stephanie Findlay HNRP investigator Dr. David Moore weighs in on how mobile technology could be an inexpensive response to taxed health care systems.  "Apps exist to help people locate the closest HIV testing site......What if you could do something like an HIV rapid test using an app on your phone? That could be a game changer in terms of HIV incidence."  The article describes the overwhelming response of text messages U-Report, a text-message based HIV counseling hotline, receives from HIV-infected Zambian teenagers asking "brutally honest" questions related to the infection. 


The First HIV/AIDS Generation Reaches Retirement Age

Newsweek published an article by Erika Hayasaki on September 18, 2014, "The First HIV/AIDS Generation Reaches Retirement Age".  The article covers many of the issues of an aging HIV infected population.  These issues are the impetus of HNRP research focusing on prospective memory, adherence to medication, comorbid aging conditions such as diabetes and cardiovascular disease, and neurological conditions such as dementia.

Click Here to link to the full article.



Newly Funded Grant - Endocannabinoids, Cannabis, and Neurocognitive Deficits in HIV

Dr. Brook Henry received notice of funding for his study that will examine dose response interaction between cannabis use and the endocannabinoid (EC) system.

Previous studies have indicated that the anti-inflammatory and neuroprotective properties of the EC system may have therapeutic utility in reducing HIV-induced damage to the central nervous system, including preventing the development of HIV-associated neurocognitive disorders (HAND).  In contrast, cannabis use is reported to induce neurocognitive and functional impairment after chronic exposure.


CHARTER Manuscript Highlighted in Neurology

Dr. Igor Grant and the CHARTER Group have a featured article in the June 2014 issue of Neurology,  “Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline”.  Their study presents further evidence that HIV-associated neurocognitive disorders remain prevalent despite combination antiretroviral therapy.  The study demonstrates that early asymptomatic neurocognitive impairment (ANI) confers an increased risk and faster development of functional/symptomatic decline in individuals with HIV disease progression.  These findings highlight the importance of identifying those with ANI in the clinic early on to offer an opportunity to modify treatment to delay progression to symptomatic/functional decline.

Click Here for link to Pubmed - and full article when available in Pubmed Central.


Copyright ©2013 HIV Neurobehavioral Research Program | University of California, San Diego
For questions regarding this site, please contact the webmaster